Hosted on MSN1mon
Seaport's Glyph platform shows 55% drug absorption in lymphaticsBOSTON - Seaport Therapeutics, a clinical-stage biopharmaceutical company, has published new research demonstrating significant advancements in drug delivery through the lymphatic system using its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback